AltruBio
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
505 Montgomery St Fl 11, San Francisco, ...Phone Number
(415) 655-6618Website
www.altrubio.comRevenue
$11.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About AltruBio
AltruBio is a global biopharmaceutical organization that focuses on the development of targeted antibody therapeutics for the treatment of cancer and immune related inflammatory disease. We are looking for innovative scientists of different levels to join our rapidly expanding R&D teams.Explore more
AltruBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AltruBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if AltruBio has recently received funding, and reach out quickly before it becomes old news!
AltruBio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when AltruBio launches new products
Funding: Get notified immidiatlly once AltruBio has new funding data
Congratulate Masked Content for being promoted to Masked Content at AltruBio
Website visits: Recent activity has been detected on your website
Check out if AltruBio is spiking on competitors!
Click to see if AltruBio had a recent Job posting/layoffs
Earning: See what the market has to say on AltruBio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at AltruBio
Find 3 more new buyers
Compare Similar Companies to AltruBio
Compare insights from companies similar to AltruBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
AltruBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AltruBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AltruBio.
AltruBio financials insights
Gather financial insights about AltruBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$63M
2024
Series B
$225M
AltruBio Tech Stack
A closer look at the technologies used by AltruBio
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
AltruBio News & Media
AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB-268’s Efficacy in T Cell-Mediated Inflammatory Models
ALTB-268 demonstrated therapeutic potential in murine models of colitis and GvHD, supporting its role as an immune checkpoint enhancer in T cell-mediated inflammatory diseasesAltruBio Announces Formation of Scientific Advisory Board
World-renowned researchers with extensive experience in immunology and autoimmune diseases join AltruBio to support scientific advancements and pipeline development World-renowned researchers with extensive experience in immunology and autoimmune diseases join AltruBio to support scientific advancements and pipeline developmentAltruBio to Participate in the Upcoming Jefferies London Healthcare Conference and the Piper Sandler 36th Annual Healthcare Conference
SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical-stage biotech company developing novel immune checkpoint enhancers to address the unmet need in immunological and inflammatory diseases, with a current focus on ulcerative colitis (UC), today announced that members of its management team will participate in two upcoming investor conferences.AltruBio Presents New In Vivo data for ALTB-268 at the 9th FIMSA 2024 Congress
ALTB-268 demonstrated its anti-inflammatory effect in an acute colitis hPSGL-1 mouse model.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AltruBio
Sign Up For FreeTo access detailed company insights
AltruBio is a global biopharmaceutical organization that focuses on the development of targeted antibody therapeutics for the treatment of cancer and immune related inflammatory disease. We are looking for innovative scientists of different levels to join our rapidly expanding R&D teams.... Read More
